Recombinant Human Interleukin 29 (interferon, lambda 1)

• Cat.No.: IL29-602H
• Product Overview: Recombinant human IL29was expressed in HEK 293 cells.

Specification

• Species: Human
• Source: HEK293
• Tag: Non
• Description: IL-29 hasimmunomodulatory activity and may function in antiviral immunity. This cytokineis produced in a serum-free, chemically defined media. Production in human293 cells offers authentic human glycosylation which contributes to stabilityin cell growth media and other applications. The purity is greater than 95%.
• Purity: >95% The proteinwas resolved by SDS polyacrylamide gel electrophoresis and the gel wasstained with Coomassie blue.
• Molecular Weight: 29 and 35 kDamonomer, glycosylated.
• Endotoxin: Endotoxin Free <1EU/ug
• Biological Activity: 0.5 to 5 ng/mL ED50
• Specific Activity: The specificactivity was determined by the dose dependent protection of the cytopathiceffect on A549 cells (human lung adenocarcinoma epithelial cell line) thatwere challenged with encephalomyocarditis (EMC) virus.
• OfficialSymbol: IL29

Gene Information

• Gene Name: IL29 interleukin 29(interferon, lambda 1) [ Homo sapiens ]
• Synonyms: IL29; interleukin 29(interferon, lambda 1); IFNL1; IL-29; interleukin-29; IFN-lambda-1; cytokineZcyto21; interferon lambda-1; interferon, lambda 1
• Gene ID: 282618
• mRNA Refseq: NM_172140
• Protein Refseq: NP_742152
• MIM: 607403
• UniProt ID: Q8IU54
• Chromosome Location: 19q13.13
• Pathway: Jak-STAT signalingpathway; Cytokine-cytokine receptor interaction
• Function: cytokine activity; interleukin-28receptor binding; receptor binding